Skip to main content
. 2020 Apr 29;4(1):e000630. doi: 10.1136/bmjpo-2019-000630

Figure 5.

Figure 5

Association between rhGH-treated group and the no treatment group related to Z-BMI in RCTs (RevMan 5.3). (A) Random sequence generation (selection bias). (B) Allocation concealment (selection bias). (C) Blinding of participants and personnel (performance bias). (D) Blinding of outcomes assessment (detection bias). (E) Incompleted outcome data (attrition bias). (F) Selective reporting (reporting bias). (G) Intention-to-treat. (H) Sample size determination. (I) Outcome. (J) Early interruption. (K) Prognostic characteristics. BMI,body mass index; RCTs, randomised controlled trials; rhGH, recombinant human growthhormone.